KRYS vs VICI · P/E 46, rev $235.6M vs P/E 9.3, rev $2.08B
Krystal Biotech Inc (KRYS) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported VICI revenue for 2026-06-30 was $2.08B. Net income was $1.40B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the KRYS and VICI stock pages for the full models.
Not investment advice.